Balanced news tone
News Sentiment
600062 sentiment intelligence
China Resources Double-Crane Pharmaceutical Co.,Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
68/100 classification confidence.
directly relevant articles
high-authority source matches
+2.2% over one week, +3.4% over four weeks, trend inactive, and near fair-value range.
China Resources Pharmaceutical Group (HKEX: 3320) announced that its subsidiary, China Resources Double-Crane, is participating in a potential acquisition of equity interests in Lier Chemical.
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
China Resources Pharmaceutical Group (HKEX: 3320) announced that its subsidiary, China Resources Double-Crane, is participating in a potential acquisition of equity interests in Lier Chemical.
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 16 Jul 2026 16:21
- Source
- 富途牛牛
HK Stock Market Alert | China Resources Pharmaceutical (03320.HK) rises over 3%; subsidiary CR Double-Crane participates in potential acquisition of partial equity stake in Lier Chemical
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 16 Jul 2026 12:18
- Source
- Moomoo
China Resources Double-Crane to Acquire Lier Chemical for 2.37 Billion Yuan, Accelerating Synbio Commercialization
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 07:55
- Source
- finance.biggo.com
Fierce Competition Among Contenders! China Resources Double-Crane Emerges as Top Preferred Bidder for Lier Chemical, Outpacing Two Sichuan State-Owned Enterprises | Quick Read Announcement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 15:25
- Source
- 富途牛牛
China Resources Double-Crane Pharmaceutical Co.,Ltd. proposed to acquire 23.5% stake in Lier Chemical Co.,LTD. from Sichuan Chemical Technology Co., Ltd. and Sichuan Jiuyuan Investment Holding Group Ltd.
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 14 Jul 2026 22:00
- Source
- marketscreener.com
Sequoia China Acquires Bayer's Cash Cow: Seeking Bargains in the Pharmaceutical Industry
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 04 Nov 2025 08:00
- Source
- 36 Kr
China Resources: From Snow Beer to Microchips - How One Company Touches Every Part of Life in China
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 03 Sep 2025 07:00
- Source
- Growth Dragons